ID   CDKL1_HUMAN             Reviewed;         357 AA.
AC   Q00532; Q2M3A4; Q6QUA0; Q8WXQ5;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 5.
DT   15-MAR-2017, entry version 162.
DE   RecName: Full=Cyclin-dependent kinase-like 1;
DE            EC=2.7.11.22;
DE   AltName: Full=Protein kinase p42 KKIALRE;
DE   AltName: Full=Serine/threonine-protein kinase KKIALRE;
GN   Name=CDKL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLU-274.
RX   PubMed=1639063;
RA   Meyerson M., Enders G.H., Wu C.-L., Su L.-K., Gorka C., Nelson C.,
RA   Harlow E., Tsai L.-H.;
RT   "A family of human cdc2-related protein kinases.";
RL   EMBO J. 11:2909-2917(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Hu W.-X., Tang L.-J., Shi Y.-W.;
RT   "The cloning of 2nd splicing version of human serine/threonine-protein
RT   kinase KKIALRE (cyclin-dependent kinase like-1).";
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANTS PRO-66;
RP   GLU-274; VAL-329 AND ASN-341.
RG   NIEHS SNPs program;
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=9000130;
RA   Taglienti C.A., Wysk M., Davis R.J.;
RT   "Molecular cloning of the epidermal growth factor-stimulated protein
RT   kinase p56 KKIAMRE.";
RL   Oncogene 13:2563-2574(1996).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLU-274 AND VAL-329.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9000130}.
CC       Nucleus {ECO:0000269|PubMed:9000130}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q00532-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q00532-2; Sequence=VSP_041239, VSP_041240, VSP_041241,
CC                                  VSP_041242;
CC   -!- TISSUE SPECIFICITY: Highly expressed in kidney, and to a lower
CC       extent in ovary. {ECO:0000269|PubMed:9000130}.
CC   -!- DOMAIN: The [NKR]KIAxRE motif seems to be a cyclin-binding region.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI04978.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAS00095.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAA47002.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cdkl1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X66358; CAA47002.1; ALT_INIT; mRNA.
DR   EMBL; X66359; CAA47002.1; JOINED; mRNA.
DR   EMBL; AF390028; AAL58838.1; -; mRNA.
DR   EMBL; AY525548; AAS00095.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL359397; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC104977; AAI04978.1; ALT_INIT; mRNA.
DR   PIR; S22745; S22745.
DR   PIR; S23383; S23383.
DR   RefSeq; NP_004187.2; NM_004196.4.
DR   RefSeq; XP_005268214.1; XM_005268157.2.
DR   RefSeq; XP_016877218.1; XM_017021729.1.
DR   UniGene; Hs.280881; -.
DR   UniGene; Hs.679430; -.
DR   PDB; 4AGU; X-ray; 2.40 A; A/B/C=1-300.
DR   PDBsum; 4AGU; -.
DR   ProteinModelPortal; Q00532; -.
DR   SMR; Q00532; -.
DR   BioGrid; 114341; 13.
DR   IntAct; Q00532; 5.
DR   STRING; 9606.ENSP00000379176; -.
DR   BindingDB; Q00532; -.
DR   ChEMBL; CHEMBL5789; -.
DR   GuidetoPHARMACOLOGY; 1982; -.
DR   iPTMnet; Q00532; -.
DR   PhosphoSitePlus; Q00532; -.
DR   BioMuta; CDKL1; -.
DR   DMDM; 229463050; -.
DR   MaxQB; Q00532; -.
DR   PaxDb; Q00532; -.
DR   PeptideAtlas; Q00532; -.
DR   PRIDE; Q00532; -.
DR   DNASU; 8814; -.
DR   Ensembl; ENST00000395834; ENSP00000379176; ENSG00000100490.
DR   GeneID; 8814; -.
DR   KEGG; hsa:8814; -.
DR   UCSC; uc001wxz.5; human. [Q00532-1]
DR   CTD; 8814; -.
DR   DisGeNET; 8814; -.
DR   GeneCards; CDKL1; -.
DR   HGNC; HGNC:1781; CDKL1.
DR   HPA; HPA059605; -.
DR   HPA; HPA065919; -.
DR   MIM; 603441; gene.
DR   neXtProt; NX_Q00532; -.
DR   PharmGKB; PA26317; -.
DR   eggNOG; KOG0593; Eukaryota.
DR   eggNOG; ENOG410XNSW; LUCA.
DR   HOGENOM; HOG000233024; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; Q00532; -.
DR   KO; K08824; -.
DR   OrthoDB; EOG091G0BZP; -.
DR   PhylomeDB; Q00532; -.
DR   TreeFam; TF101031; -.
DR   BRENDA; 2.7.11.22; 2681.
DR   SignaLink; Q00532; -.
DR   GenomeRNAi; 8814; -.
DR   PRO; PR:Q00532; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000100490; -.
DR   CleanEx; HS_CDKL1; -.
DR   ExpressionAtlas; Q00532; baseline and differential.
DR   Genevisible; Q00532; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Kinase; Nucleotide-binding; Nucleus; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    357       Cyclin-dependent kinase-like 1.
FT                                /FTId=PRO_0000085810.
FT   DOMAIN        4    287       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      10     18       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF        45     51       [NKR]KIAxRE.
FT   ACT_SITE    126    126       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      33     33       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   VAR_SEQ       1      1       M -> MELSTDTGWNQKSNFPPCDSRVSKEEAQLPFPTPSS
FT                                YGADSSNQTYAHKSQSEREQHKEVRAVLNHCSGLDGGEESG
FT                                LCGTSTRIDAGTGNGTDDKVTDQHRHRRCLQGTKGNNRGSE
FT                                VWGLLLQGNVDRSGGAPSAGVLLRRRGYSCALHGLRKFANL
FT                                AGLLSRQQDSARGVSHHSRLKIHFKKIYSSMM (in
FT                                isoform 2). {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_041239.
FT   VAR_SEQ      56     56       K -> KAPSPYAAEPSLCGMKMVRRGKKEFLPAVAEKVDAP
FT                                SGVGGQGQDSVTVGSLGRRSTYGRKQEKQVRQREGIIYCYV
FT                                AVLLRIYYFDQGCVAREEEQFQELVFGPFCHIGSYFTGHRT
FT                                NVRPYILLLSRPSPFKTAAGTYEAGLVILECSYFLAEQEPY
FT                                CPTQALQQPHPIIGPWALEGGGVESKEDRHPPPKEAPASCE
FT                                GFLRSAVPKQAYTPFKTSPDKRLSDCVATPPWAPPTPLIIS
FT                                SGVLVAICSMIDPVPEFHSEGLLAKATSGSAGILVWIFLCN
FT                                DAFIYGKYILRSGVLWVRGLPGFKSEAAALCHKCYSSADPK
FT                                REQQQDLLQRVKEQSFHSVNGAQARHKGSPSPHQTQEPSWP
FT                                HPVDPTPGHRWSCLPVPCRAPALLSPWVVDGTGCCGAGGGS
FT                                DRGGSAAQEPT (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_041240.
FT   VAR_SEQ      98    121       VPEHLVKSITWQTLQAVNFCHKHN -> ICNIFVCTGRRLG
FT                                EHTEALSKKKKKGGGGPFLKLRAASCRITLFKNVGCGLETT
FT                                GDLSLNSGGGAASRGVAAALRALVCGTELTSSDSPQR (in
FT                                isoform 2). {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_041241.
FT   VAR_SEQ     247    357       EPLELKFPNISYPALGLLKGCLHMDPTQRLTCEQLLHHPYF
FT                                ENIREIEDLAKEHNKPTRKTLRKSRKHHCFTETSKLQYLPQ
FT                                LTGSSILPALDNKKYYCDTKKLNYRFPNI -> SLCLSVTL
FT                                TEGGLLASGAVKRSQMGSSVSQATSWPHPDIVAETAELDDI
FT                                AMARQTPVMLRFNRQKEQEKYLSYGA (in isoform
FT                                2). {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_041242.
FT   VARIANT      66     66       L -> P (in dbSNP:rs11570814).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_020576.
FT   VARIANT     274    274       Q -> E (in dbSNP:rs7161563).
FT                                {ECO:0000269|PubMed:1639063,
FT                                ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_020577.
FT   VARIANT     329    329       L -> V (in dbSNP:rs9323183).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_020578.
FT   VARIANT     341    341       K -> N (in dbSNP:rs11570886).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_020579.
FT   CONFLICT    152    152       A -> T (in Ref. 1; CAA47002, 2; AAL58838,
FT                                3; AAS00095 and 5; AAI04978).
FT                                {ECO:0000305}.
FT   CONFLICT    301    301       N -> D (in Ref. 1; CAA47002).
FT                                {ECO:0000305}.
FT   STRAND        4     12       {ECO:0000244|PDB:4AGU}.
FT   STRAND       14     23       {ECO:0000244|PDB:4AGU}.
FT   TURN         24     26       {ECO:0000244|PDB:4AGU}.
FT   STRAND       29     35       {ECO:0000244|PDB:4AGU}.
FT   HELIX        42     57       {ECO:0000244|PDB:4AGU}.
FT   STRAND       66     72       {ECO:0000244|PDB:4AGU}.
FT   STRAND       75     81       {ECO:0000244|PDB:4AGU}.
FT   STRAND       84     86       {ECO:0000244|PDB:4AGU}.
FT   HELIX        87     93       {ECO:0000244|PDB:4AGU}.
FT   HELIX       100    119       {ECO:0000244|PDB:4AGU}.
FT   HELIX       129    131       {ECO:0000244|PDB:4AGU}.
FT   STRAND      132    134       {ECO:0000244|PDB:4AGU}.
FT   STRAND      140    142       {ECO:0000244|PDB:4AGU}.
FT   HELIX       165    167       {ECO:0000244|PDB:4AGU}.
FT   HELIX       170    174       {ECO:0000244|PDB:4AGU}.
FT   HELIX       182    197       {ECO:0000244|PDB:4AGU}.
FT   HELIX       207    218       {ECO:0000244|PDB:4AGU}.
FT   HELIX       223    230       {ECO:0000244|PDB:4AGU}.
FT   HELIX       233    235       {ECO:0000244|PDB:4AGU}.
FT   HELIX       249    252       {ECO:0000244|PDB:4AGU}.
FT   HELIX       258    267       {ECO:0000244|PDB:4AGU}.
FT   TURN        272    274       {ECO:0000244|PDB:4AGU}.
FT   HELIX       278    282       {ECO:0000244|PDB:4AGU}.
FT   HELIX       285    287       {ECO:0000244|PDB:4AGU}.
SQ   SEQUENCE   357 AA;  41671 MW;  3EA30F059885F846 CRC64;
     MEKYEKIGKI GEGSYGVVFK CRNRDTGQIV AIKKFLESED DPVIKKIALR EIRMLKQLKH
     PNLVNLLEVF RRKRRLHLVF EYCDHTVLHE LDRYQRGVPE HLVKSITWQT LQAVNFCHKH
     NCIHRDVKPE NILITKHSVI KLCDFGFARL LAGPSDYYTD YVATRWYRSP ELLVGDTQYG
     PPVDVWAIGC VFAELLSGVP LWPGKSDVDQ LYLIRKTLGD LIPRHQQVFS TNQYFSGVKI
     PDPEDMEPLE LKFPNISYPA LGLLKGCLHM DPTQRLTCEQ LLHHPYFENI REIEDLAKEH
     NKPTRKTLRK SRKHHCFTET SKLQYLPQLT GSSILPALDN KKYYCDTKKL NYRFPNI
//
